Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 304

The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.

Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men

Blumeyer, Anja, Tosti, Antonella, Messenger, Andrew, Reygagne, Pascal, del Marmol, Veronique, Spuls, Phyllis I., Trakatelli, Myrto, Finner, Andreas, Kiesewetter, Franklin, Trüeb, Ralph, Rzany, Berthold, Blume‐Peytavi, Ulrike·2011·JDDG: Journal der Deutschen Dermatologischen Gesellschaft

Abstract

Summary: Androgenetic alopecia is the most common hair loss disorder, affecting both men and women. Initial signs of androgenetic alopecia usually develop during teenage years leading to progressive hair loss with a pattern distribution. Moreover, its frequency increases with age and affects up to 80 % Caucasian men and 42 % of women. Patients diagnosed with androgenetic alopecia may undergo significant impairment of quality of life. Despite the high prevalence and the variety of therapeutic options available, there have been no national or international evidence‐based guidelines for the treatment of androgenetic alopecia in men and women so far. Therefore, the European Dermatology Forum (EDF) initiated a project to develop an evidence‐based S3 guideline for the treatment of andro‐genetic alopecia. Based on a systematic literature research the efficacy of the currently available therapeutic options was assessed and therapeutic recommendations were passed in a consensus conference. The purpose of the guideline is to provide dermatologists as well as general practitioners with an evidence‐based tool for choosing an efficacious and safe therapy for patients with androgenetic alopecia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1610-0379.2011.07802.x

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 54 references

Cited by

See all 304

Metadata

Authors
Blumeyer, A., Tosti, A., Messenger, A., Reygagne, P., del Marmol, V., Spuls, P. I., Trakatelli, M., Finner, A., Kiesewetter, F., Trüeb, R., Rzany, B., & Blume‐Peytavi, U.
Venue
JDDG: Journal der Deutschen Dermatologischen Gesellschaft
Publisher
Wiley
Published
2011-10
Volume
9
Issue
s6
Pages
S1-57
ISSN
  • 1610-0379 (ISSN-L)
  • 1610-0387
OpenAlex
W2007372522
Cited by
304
References
54
FWCI
14.90
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men. https://app.cochat.ai/papers/10.1111/j.1610-0379.2011.07802.x
The paper
Blumeyer, A., Tosti, A., Messenger, A., Reygagne, P., del Marmol, V., Spuls, P. I., Trakatelli, M., Finner, A., Kiesewetter, F., Trüeb, R., Rzany, B., & Blume‐Peytavi, U. (2011). Evidence‐based (S3) guideline for the treatment of androgenetic alopecia in women and in men. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/j.1610-0379.2011.07802.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.